These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 562941)
1. Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration. Cannon JG; Lee T; Goldman HD J Med Chem; 1977 Sep; 20(9):1111-6. PubMed ID: 562941 [TBL] [Abstract][Full Text] [Related]
2. Differential activation by some 2-aminotetralin derivatives of the receptor mechanisms in the nucleus accumbens of rats which mediate hyperactivity and stereotyped biting. Costall B; Naylor RJ; Cannon JG; Lee T Eur J Pharmacol; 1977 Feb; 41(3):307-19. PubMed ID: 556988 [TBL] [Abstract][Full Text] [Related]
3. Derivatives of 5-hydroxy-6-methyl-2-aminotetralin. Cannon JG; Koble DL; Long JP; Verimer T J Med Chem; 1980 Jul; 23(7):750-4. PubMed ID: 6249931 [TBL] [Abstract][Full Text] [Related]
4. Effect of non-catecholic 2-aminotetralin derivatives on dopamine metabolism in the rat striatum. Feenstra MG; Rollema H; Dijkstra D; Grol CJ; Horn AS; Westerink BH Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):213-9. PubMed ID: 7432553 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN. Stoof JC; Horn AS; Mulder AH Brain Res; 1980 Aug; 196(1):276-81. PubMed ID: 7397528 [No Abstract] [Full Text] [Related]
6. [Effect of 2 N-substituted aminotetralin derivatives with antihypertensive action on the monoamine oxidase activity of brain and liver preparations]. Bogoslovova T; Staneva-Stoĭcheva D Eksp Med Morfol; 1987; 26(4):40-4. PubMed ID: 3128443 [No Abstract] [Full Text] [Related]
7. Topographical analysis of the actions of 2(N,N-dipropyl)amino-5,6-dihydroxytetralin to cause biting behaviour and locomotor hyperactivity from the striatum of the guinea-pig. Costall B; De Souza CX; Naylor RJ Neuropharmacology; 1980 Jul; 19(7):623-31. PubMed ID: 7190654 [No Abstract] [Full Text] [Related]
8. Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents. Seiler MP; Stoll AP; Closse A; Frick W; Jaton A; Vigouret JM J Med Chem; 1986 Jun; 29(6):912-7. PubMed ID: 3712381 [TBL] [Abstract][Full Text] [Related]
9. N-Isopropyl derivatives of dopamine and 5,6-dihydroxy-2-aminotetralin. Cannon JG; O'Donnell JP; Lee T; Hoppin CR; Long JP; Ilhan M; Costall B; Naylor RJ J Med Chem; 1975 Dec; 18(12):1212-6. PubMed ID: 497 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity. Vermue NA; Kaptein B; Tepper PG; de Vries JB; Horn AS Arch Int Pharmacodyn Ther; 1988; 293():37-56. PubMed ID: 3421784 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins. Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183 [TBL] [Abstract][Full Text] [Related]
13. The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors. Van der Weide J; Tendijck ME; Tepper PG; De Vries JB; Dubocovich ML; Horn AS Eur J Pharmacol; 1988 Feb; 146(2-3):319-26. PubMed ID: 2836210 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734. Van der Weide J; De Vries JB; Tepper PG; Horn AS Eur J Pharmacol; 1986 Jun; 125(2):273-82. PubMed ID: 3743637 [TBL] [Abstract][Full Text] [Related]
15. QSAR of N-alkylated 2-aminotetralins as central dopamine receptor stimulating agents. Lien EJ; Nilsson JL Acta Pharm Suec; 1983; 20(4):271-6. PubMed ID: 6637518 [No Abstract] [Full Text] [Related]
16. In vivo dopamine receptor agonist binding in rat brain: relation with pharmacological effects. Feenstra MG; Rollema H; Mulder TB; De Vries JB; Horn AS Eur J Pharmacol; 1983 Jun; 90(4):433-6. PubMed ID: 6684056 [TBL] [Abstract][Full Text] [Related]
17. Assessment of a potential dopaminergic prodrug moiety in several ring systems. Cannon JG; Furlano DC; Dushin RG; Chang YA; Baird SR; Soliman LN; Flynn JR; Long JP; Bhatnagar RK J Med Chem; 1986 Oct; 29(10):2016-20. PubMed ID: 3761320 [TBL] [Abstract][Full Text] [Related]
20. In vivo dopamine autoreceptor selectivity appears to be critically dependent upon the aromatic hydroxyl position in a series of N,N-disubstituted 2-aminotetralins. Van Oene JC; De Vries JB; Dijkstra D; Renkema RJ; Tepper PG; Horn AS Eur J Pharmacol; 1984 Jun; 102(1):101-15. PubMed ID: 6434327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]